Microparticles: Modulators and biomarkers of liver disease

Slides:



Advertisements
Similar presentations
 The stimulation of a variety of cell types may lead to the release of microparticles (MPs)  These submicron vesicles bud off from the plasma membrane.
Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Exosomes as Biomarker Treasure Chests for Prostate Cancer
Jean Dubuisson, François-Loïc Cosset  Journal of Hepatology 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Tiny RNA with great effects: miR-155 in alcoholic liver disease
Nat. Rev. Nephrol. doi: /nrneph
Pathological roles of purinergic signaling in the liver
The inflammasome in liver disease
Anatoliy I. Masyuk, Tatyana V. Masyuk, Nicholas F. LaRusso 
Mirjam B. Zeisel, Isabel Fofana, Samira Fafi-Kremer, Thomas F. Baumert 
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
GRASPing Unconventional Secretion
Immigration and viral hepatitis
Regulatory T-cell directed therapies in liver diseases
The evidence supports a viral aetiology for primary biliary cirrhosis
Living donor liver transplantation: is the hype over?
The origin of cancer stem cells
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Volume 44, Issue 3, Pages (March 2006)
Jeffrey D. McBride, Luis Rodriguez-Menocal, Evangelos V. Badiavas 
Biology of the immunomodulatory molecule HLA-G in human liver diseases
Regulatory T-cell directed therapies in liver diseases
Hepatitis C core protein – The “core” of immune deception?
Signalling pathways in alcohol-induced liver inflammation
Exosomes in liver pathology
Targeting gut flora to prevent progression of hepatocellular carcinoma
Volume 70, Issue 1, Pages (January 2019)
Biomarkers of liver cell death
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Autophagy in the liver Journal of Hepatology
Volume 59, Issue 3, Pages (September 2013)
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
Veronika Lukacs-Kornek, Detlef Schuppan  Journal of Hepatology 
HCMV jogs the ‘memory’ of NK cells in HBV
S. Tamir Rashid, Graeme J.M. Alexander  Journal of Hepatology 
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Salvatore Papa, Concetta Bubici  Journal of Hepatology 
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
The use of hemospray in portal hypertensive bleeding; a case series
Jean Dubuisson, François-Loïc Cosset  Journal of Hepatology 
Volume 62, Issue 3, Pages (March 2015)
Autophagy in liver diseases: Time for translation?
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Tatiana Kisseleva, David A. Brenner  Journal of Hepatology 
Statins: Old drugs as new therapy for liver diseases?
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Chimeric mouse model of hepatitis B virus infection
Volume 54, Issue 6, Pages (June 2011)
Genetics of hepatocellular carcinoma: The next generation
Volume 61, Issue 2, Pages (August 2014)
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Presentation transcript:

Microparticles: Modulators and biomarkers of liver disease Miroslaw Kornek, Detlef Schuppan  Journal of Hepatology  Volume 57, Issue 5, Pages 1144-1146 (November 2012) DOI: 10.1016/j.jhep.2012.07.029 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Microparticles: origin, characteristics and biological effects. (A) Characteristics of exosomes, microparticles (MP), apoptotic bodies and living cells regarding phosphatidylserine (PS, annexin V) orientation within their membranes. PS is found preferentially in the inner leaflet of the cell membrane of living cells. Exosomes, MP and apoptotic bodies are incapable to maintain the asymmetry of their bilayer cell membrane due to lack of flippase activity, permitting their detection with antibodies to annexin V or dye labelled recombinant annexin V in FACS analysis. Exosomes are formed intracellularly, stored within endosomal vesicles and released by an energy-consuming process, while MP are released by plasma membrane blebbing resulting in vesicles equipped with parts of the parental cell membrane. (B) Simplified overview of the most recently studied cell types and accompanying MP populations as found in the peripheral blood [4,8,10,11,15–17]. MP are released from multiple cell types and fuse with plasma membranes of other cells, including hepatic stellate and vascular endothelial cells. Insert (C) shows how cytosolic proteins, mRNA, microRNA or other components stored in the lumen of MP can be transferred to a recipient cell (i–iii). In addition, membrane fusion can transfer receptors from MP altering receptor-mediated signal transduction in the recipient cells. Journal of Hepatology 2012 57, 1144-1146DOI: (10.1016/j.jhep.2012.07.029) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions